Sanofi, a global biopharmaceutical company based in France, manufactures drugs to treat diabetes, meningitis and various forms of cancer. The company has also manufactured a vaccine to prevent COVID-19 infections, which was recently found to be effective against Omicron-related cases, according to Reuters.
Months into the COVID-19 pandemic, researchers observed an uptick in mobile phishing attempts targeting the pharmaceutical industry. Cyberattack trends have led to the hardening of pharmaceutical companies’ attack surfaces.
To assure compliance and bolster cybersecurity, Sanofi implemented the Security Platform & Compliance Monitor from SecurityBridge. The company’s security approach combines application security and analyzes the system’s security in a central location, as well as automates the systems application and products (SAP) security process.
The Security Platform & Compliance Monitor helped centralize overview for missing security notes; security management of all Sanofi SAP systems, including software and hardware; traffic monitoring and security information and event management (SIEM) integrations.
